Publication: Prechemoradiotherapy number of natural teeth as a prognostic factor in patients with locally advanced nasopharyngeal cancer: A retrospective observational study
Program
KU-Authors
KU Authors
Co-Authors
Topkan, Erkan (55885460400)
Somay, Efsun (57215523038)
Bascil, Sibel (55341551200)
Öztürk, Duriye (55439871500)
Selek, Uǧur (6603453640)
Publication Date
Language
Type
Embargo Status
No
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Objective: This study evaluated the prognostic value of the pretreatment number of natural teeth on progression-free survival and overall survival in patients with locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy. Methods: We retrospectively analyzed 248 patients with locally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy–based concurrent chemoradiotherapy and adjuvant chemotherapy between June 2010 and December 2021. The number of natural teeth was assessed before concurrent chemoradiotherapy. A receiver operating characteristic curve analysis was performed to identify the optimal number of natural teeth threshold predictive of overall survival and progression-free survival. Results: The optimal cutoff value for the number of natural teeth was 19.5 (area under the curve: 70.6%). Patients were grouped into those with a number of natural teeth <20 (n = 76) and those with a number of natural teeth ≥20 (n = 172). The number of natural teeth ≥20 group had significantly improved overall survival (not reached vs. 71.0 months; p < 0.001) and progression-free survival (117 vs. 38.0 months; p < 0.001). Multivariate analysis confirmed the number of natural teeth <20 as an independent predictor of worse outcomes. Conclusions: A pretreatment number of natural teeth <20 independently predicts poorer survival in patients with locally advanced nasopharyngeal carcinoma receiving concurrent chemoradiotherapy, suggesting that the number of natural teeth may serve as a simple, accessible prognostic biomarker in head and neck oncology. © 2025 Elsevier B.V., All rights reserved.
Source
Publisher
SAGE Publications Ltd
Subject
Citation
Has Part
Source
Journal of International Medical Research
Book Series Title
Edition
DOI
10.1177/03000605251379977
item.page.datauri
Link
Rights
Copyrighted
